Fritsche TR - Search Results

1

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).

Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Biedenbach DJ, et al. Among authors: fritsche tr. Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24. Int J Antimicrob Agents. 2007. PMID: 17531446

2

Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.

Johnson DM, Sader HS, Fritsche TR, Biedenbach DJ, Jones RN. Johnson DM, et al. Among authors: fritsche tr. Diagn Microbiol Infect Dis. 2003 Sep;47(1):373-6. doi: 10.1016/s0732-8893(03)00089-0. Diagn Microbiol Infect Dis. 2003. PMID: 12967753

3

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

Fritsche TR, Stilwell MG, Jones RN. Fritsche TR, et al. Clin Microbiol Infect. 2005 Dec;11(12):974-84. doi: 10.1111/j.1469-0691.2005.01271.x. Clin Microbiol Infect. 2005. PMID: 16307551 Free article.

4

Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).

Rhomberg PR, Fritsche TR, Sader HS, Jones RN. Rhomberg PR, et al. Among authors: fritsche tr. J Chemother. 2005 Oct;17(5):459-69. doi: 10.1179/joc.2005.17.5.459. J Chemother. 2005. PMID: 16323433

5

Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.

Sader HS, Fritsche TR, Streit JM, Jones RN. Sader HS, et al. Among authors: fritsche tr. J Chemother. 2005 Oct;17(5):477-83. doi: 10.1179/joc.2005.17.5.477. J Chemother. 2005. PMID: 16323435

6

Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.

Jones RN, Fritsche TR, Sader HS, Goldstein BP. Jones RN, et al. Among authors: fritsche tr. J Chemother. 2005 Dec;17(6):593-600. doi: 10.1179/joc.2005.17.6.593. J Chemother. 2005. PMID: 16433188

7

Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).

Sader HS, Streit JM, Fritsche TR, Jones RN. Sader HS, et al. Among authors: fritsche tr. Clin Microbiol Infect. 2006 Sep;12(9):844-52. doi: 10.1111/j.1469-0691.2006.01550.x. Clin Microbiol Infect. 2006. PMID: 16882289 Free article.

8

Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers.

Sader HS, Watters AA, Fritsche TR, Jones RN. Sader HS, et al. Among authors: fritsche tr. J Chemother. 2008 Feb;20(1):28-32. J Chemother. 2008. PMID: 18343740

9

Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).

Fritsche TR, Biedenbach DJ, Jones RN. Fritsche TR, et al. J Chemother. 2008 Apr;20(2):170-4. doi: 10.1179/joc.2008.20.2.170. J Chemother. 2008. PMID: 18467241

10

Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients.

Sader HS, Fritsche TR, Jones RN. Sader HS, et al. Among authors: fritsche tr. J Chemother. 2008 Oct;20(5):570-6. doi: 10.1179/joc.2008.20.5.570. J Chemother. 2008. PMID: 19028618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page